Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols

Author(s):
Huisman, M.V. (0000-0003-1423-5348); Fanikos, J.
Published
2016
Publication type
Article / Letter to editor
Anticoagulation reversal protocolsDirect oral anticoagulantsHospital guidelinesIdarucizumabLife-threatening bleedingUncontrolled bleeding
Date issued
2016-11-30
Language
English
Is part of
American Journal of Medicine (2016), Vol. 129, no. 11, p. S89-S96
hdl
1887/112225
doi
10.1016/j.amjmed.2016.06.010